Table 2.
Summary of human type III activity
| DHP ⇒ allopregnanolone | |||
|---|---|---|---|
| Km, nM | Vmax, nmol/mg/min | Enzyme efficiency | |
| DHP alone | 7.2 ± 0.01 | 126 ± 0.44 | 17.5 |
| (+)fluoxetine | 0.63 ± 0.01 | 169.8 ± 0.56 | 269.5 |
| (+)paroxetine | 0.26 ± 0.01 | 82.13 ± 0.69 | 316.5 |
| (+)sertraline | 0.69 ± 0.03 | 120.1 ± 0.57 | 174.1 |
| (+)imipramine | 9.93 ± 0.04 | 114.2 ± 3.53 | 11.5 |
| Allopregnanolone ⇒ DHP | |||
|---|---|---|---|
| Km, μM | Vmax, nmol/mg/min | Enzyme efficiency | |
| Allo alone | 43.0 ± 0.02 | 7.1 ± 0.01 | 0.0002 |
| (+)fluoxetine | 30.9 ± 0.03 | 27.0 ± 0.37 | 0.0008 |
| (+)paroxetine | 15.0 ± 0.01 | 8.9 ± 0.01 | 0.0006 |
| (+)sertraline | 130.4 ± 0.16 | 10.8 ± 0.43 | 0.00008 |
| (+)imipramine | 71.4 ± 0.22 | 39.0 ± 3.33 | 0.0005 |
Mean ± SE.